Outcome of Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia after Blinatumomab Failure: No Change in the Level of CD19 Expression

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - November 27, 2017 Category: Hematology Authors: Elias Jabbour, Johannes D üll, Musa Yilmaz, Joseph D. Khoury, Farhad Ravandi, Nitin Jain, Hermann Einsele, Guillermo Garcia‐Manero, Marina Konopleva, Nicholas J. Short, Philip A. Thompson, William Wierda, Naval Daver, Jorge Cortes, Susan O'Brien, Hagop Tags: Research Article Source Type: research